1. Home
  2. ARDX vs LYTS Comparison

ARDX vs LYTS Comparison

Compare ARDX & LYTS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Ardelyx Inc.

ARDX

Ardelyx Inc.

SELL

Current Price

$3.24

Market Cap

862.3M

Sector

Health Care

ML Signal

SELL

Logo LSI Industries Inc.

LYTS

LSI Industries Inc.

SELL

Current Price

$20.72

Market Cap

912.7M

ML Signal

SELL

Company Overview

Basic Information
Metric
ARDX
LYTS
Founded
2007
1976
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Building Products
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
862.3M
912.7M
IPO Year
2014
1994

Fundamental Metrics

Financial Performance
Metric
ARDX
LYTS
Price
$3.24
$20.72
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
11
3
Target Price
$12.90
★ $30.00
AVG Volume (30 Days)
★ 4.1M
354.8K
Earning Date
10-29-2026
11-05-2026
Dividend Yield
N/A
★ 0.97%
EPS Growth
N/A
★ N/A
EPS
N/A
★ 0.67
Revenue
$2,607,000.00
★ $573,377,000.00
Revenue This Year
$19.98
$28.38
Revenue Next Year
$27.70
$7.65
P/E Ratio
★ N/A
$30.81
Revenue Growth
N/A
★ 22.09
52 Week Low
$3.18
$17.21
52 Week High
$8.40
$27.36

Technical Indicators

Market Signals
Indicator
ARDX
LYTS
Relative Strength Index (RSI) 29.24 48.41
Support Level N/A $18.38
Resistance Level $3.63 $21.22
Average True Range (ATR) 0.11 0.58
MACD 0.01 0.06
Stochastic Oscillator 12.50 51.59

Price Performance

Historical Comparison
ARDX
LYTS

About ARDX Ardelyx Inc.

Ardelyx Inc is a biopharmaceutical company developing and commercialize, first-in-class medicines that meet unmet medical needs. It has developed a platform that enabled the discovery of new biological mechanisms and pathways to develop potent and efficacious therapies that minimize the side effects and drug-drug interactions frequently encountered with traditional, systemically absorbed medicines. Its products Tenapanor, branded as IBSRELA, is used for the treatment of adults with IBS-C. Tenapanor, branded as XPHOZAH, is used to reduce serum phosphorus in adults with CKD on dialysis as add-on therapy in patients who have an inadequate response to phosphate binders or who are intolerant of any dose of phosphate binder therapy.

About LYTS LSI Industries Inc.

LSI Industries Inc provides corporate visual image solutions to the petroleum and convenience store industry. The company's operating segments include Lighting and Display Solutions. It generates maximum revenue from the Display solutions segment. Lighting Segment manufactures and markets outdoor and indoor lighting and lighting controls for the commercial, industrial, and multi-site retail markets, including the petroleum/convenience store, quick-service, and automotive markets. The Display Solutions Segment manufactures, sells, and installs exterior and interior visual image and display elements, including printed graphics, structural graphics, digital signage, menu board systems, display fixtures, refrigerated displays, and custom display elements.

Share on Social Networks: